Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1704230rdf:typepubmed:Citationlld:pubmed
pubmed-article:1704230lifeskim:mentionsumls-concept:C0019169lld:lifeskim
pubmed-article:1704230lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:1704230lifeskim:mentionsumls-concept:C0677626lld:lifeskim
pubmed-article:1704230lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:1704230lifeskim:mentionsumls-concept:C0042774lld:lifeskim
pubmed-article:1704230lifeskim:mentionsumls-concept:C0023828lld:lifeskim
pubmed-article:1704230lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1704230lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:1704230lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:1704230lifeskim:mentionsumls-concept:C0243144lld:lifeskim
pubmed-article:1704230pubmed:issue2lld:pubmed
pubmed-article:1704230pubmed:dateCreated1991-3-8lld:pubmed
pubmed-article:1704230pubmed:abstractTextAsialofetuin-tacked liposomes (AF-liposomes) encapsulating interferon (IFN)-gamma were bound and internalized into a human hepatoma cell line, HepG2 cells, selectively through asialoglycoprotein receptor, but not non-tacked liposomes (N-liposomes). AF-liposomal IFN-gamma was more effective for inhibition of viral DNA replication in hepatitis B virus (HBV)-producing clone from HepG2 cells transfected with HBV-DNA than N-liposomal IFN-gamma. AF-liposomes may increase the therapeutic potential of IFN-gamma through asialoglycoprotein receptor in treating HBV-infected hepatocytes.lld:pubmed
pubmed-article:1704230pubmed:languageenglld:pubmed
pubmed-article:1704230pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:citationSubsetIMlld:pubmed
pubmed-article:1704230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1704230pubmed:statusMEDLINElld:pubmed
pubmed-article:1704230pubmed:monthJanlld:pubmed
pubmed-article:1704230pubmed:issn0006-291Xlld:pubmed
pubmed-article:1704230pubmed:authorpubmed-author:HayashiYYlld:pubmed
pubmed-article:1704230pubmed:authorpubmed-author:HaraTTlld:pubmed
pubmed-article:1704230pubmed:authorpubmed-author:AramakiYYlld:pubmed
pubmed-article:1704230pubmed:authorpubmed-author:IshiharaHHlld:pubmed
pubmed-article:1704230pubmed:authorpubmed-author:TsuchiyaSSlld:pubmed
pubmed-article:1704230pubmed:authorpubmed-author:KoikeKKlld:pubmed
pubmed-article:1704230pubmed:issnTypePrintlld:pubmed
pubmed-article:1704230pubmed:day31lld:pubmed
pubmed-article:1704230pubmed:volume174lld:pubmed
pubmed-article:1704230pubmed:ownerNLMlld:pubmed
pubmed-article:1704230pubmed:authorsCompleteYlld:pubmed
pubmed-article:1704230pubmed:pagination839-45lld:pubmed
pubmed-article:1704230pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:meshHeadingpubmed-meshheading:1704230-...lld:pubmed
pubmed-article:1704230pubmed:year1991lld:pubmed
pubmed-article:1704230pubmed:articleTitleSpecific uptake of asialofetuin-tacked liposomes encapsulating interferon-gamma by human hepatoma cells and its inhibitory effect on hepatitis B virus replication.lld:pubmed
pubmed-article:1704230pubmed:affiliationTokyo College of Pharmacy, Japan.lld:pubmed
pubmed-article:1704230pubmed:publicationTypeJournal Articlelld:pubmed